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Background: A substantial aspect of health literacy is the knowledge of prescribed medication. 
In chronic heart failure, incomplete intake of prescribed drugs (medication non-adherence) is 
inversely associated with clinical prognosis. Therefore, we assessed medication knowledge in 
a cohort of patients with decompensated heart failure at hospital admission and after discharge 
in a prospective, cross-sectional study.
Methods: One hundred and eleven patients presenting at the emergency department with 
acute decompensated heart failure were included (mean age 78.4±9.2, 59% men) in the study. 
Patients’ medication knowledge was assessed during individual interviews at baseline, course 
of hospitalization, and 3 months after discharge. Individual responses were compared with the 
medical records of the referring general practitioner.
Results: Median N-terminal prohormone of brain natriuretic peptide plasma concentration in 
the overall population at baseline was 4,208 pg/mL (2,023–7,101 pg/mL [interquartile range]), 
20 patients died between the second and third interview. The number of prescribed drugs increased 
from 8±3 at baseline to 9±3 after 3 months. The majority of patients did not know the correct 
number of their drugs. Medication knowledge decreased continuously from baseline to the third 
interview. At baseline, 37% (n=41) of patients stated the correct number of drugs to be taken, 
whereas only 18% (n=16) knew the correct number 3 months after discharge (P=0.008). Knowl-
edge was inversely related to N-terminal prohormone of brain natriuretic peptide levels.
Conclusion: Medication knowledge of patients with acute decompensated heart failure is poor. 
Despite care in a university hospital, patients’ individual medication knowledge decreased after 
discharge. The study reveals an urgent need for better strategies to improve and promote the 
knowledge of prescribed medication in these very high-risk patients.
Keywords: medication knowledge, hospitalization, chronic heart failure, health literacy
Introduction
Chronic heart failure (CHF) is a serious health care problem affecting 1%–2% of the adult 
population in developed countries with the prevalence rising to $10% among persons 
$70 years of age.1 Evidence-based pharmacotherapy has improved prognosis in patients 
with systolic heart failure.2 Adherence to these medications, defined as the extent to which 
patients take medications as prescribed, prevents hospitalization and mortality.3,4
Management of chronic diseases, including heart failure, requires a high level of 
self-care skills that are determined by patients’ health literacy, which is defined as the 
degree to which patients have the capacity to adapt health information and services 
needed to make appropriate health decisions.4 A substantial aspect of health literacy 
represents the knowledge of one’s medical condition and treatment regimens, espe-
cially daily medication.5 Medication knowledge was shown to determine medication 
adherence in CHF patients and is inversely associated with outcomes in CHF.6,7 Lack 
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of patients’ knowledge about their discharge medication 
increases the risk of drug-related problems.4 During hospi-
talization, established medication regimens are frequently 
modified, and in .75% of cases, even three or more altera-
tions are carried out.8 A fact that represents a challenge for 
the interaction between health care providers and patients.
Cognitive functioning is impaired in patients with dec-
ompensated heart failure. It improves but does not normalize 
after recompensation
.
9,10 Several studies characterized health 
literacy and medication knowledge in CHF populations either 
at the time of hospitalization or after discharge. However, 
a potential alteration of knowledge over time from acute 
hospital admission to the outpatient setting and a potential 
role of recompensation as an effector of knowledge have 
not been investigated. We hypothesized an increase in the 
individual medication-related knowledge during the course 
of treatment. Therefore, the objective of the present study 
was to quantify medication knowledge in a cohort of patients 
referred to and discharged from a tertiary clinical center due 
to decompensated heart failure.
Methods
Patients
This evaluation is a prospective, cross-sectional study. We 
consecutively enrolled 111 patients between 54 and 98 years 
of age who had been hospitalized for decompensated heart 
failure at the emergency department of the Saarland Univer-
sity Hospital. The following inclusion criteria were required: 
acute decompensated heart failure, established medical 
therapy, and an ability to give written consent and participate 
in the interview. CHF was defined according to the European 
Society of Cardiology guidelines.2 After written informed 
consent was obtained, the patients were interviewed by an 
independent data collector not involved in patient care. The 
study was approved by the local ethics committee (“Ethik-
Kommission der Ärztekammer des Saarlandes”) (identifica-
tion number 98/13) in accordance with the Declaration of 
Helsinki. All patients gave their written informed consent 
to participate in the study.
clinical and demographic variables
Demographic characteristics (sex, age), body mass index, 
marital status, degree of education, New York Heart Asso-
ciation functional class for dyspnea, cardiovascular (CV) 
comorbidities, and admitting diagnosis were assessed 
(Table 1). Heart rate and blood pressure were measured 
at baseline after resting for at least 5 minutes. N-terminal 
prohormone of brain natriuretic peptide (NT-proBNP) levels 
were measured at baseline. The number and type (CV and 
non-CV) of medicines prescribed were documented and veri-
fied from the patient chart at admission (baseline = interview 
1) and during hospitalization at days 2–4 (second interview). 
At home, 3 months (mean 106 days) after discharge, the 
prescribed medication was verified by comparison with the 
outpatient record of the treating general practitioner.
Patient-reported medication knowledge
Fifteen types of prescribed CHF-related drugs were catego-
rized (Table 2). To determine patients’ knowledge about 
their medication, the following questions were asked: How 
many different medications do you take? How many heart-
specific medications do you take? Do you know the name 
(generic or brand)? Do you know the function/mode of 
action? Do you know the dosage form? Do you know when 
to take the medications? The patients were asked these 
questions at the time of hospitalization in the emergency 
department (baseline), in the hospital ward after stabilization 
on days 2–4 (second interview) and at home, 3 months after 
Table 1 Baseline characteristics of the study population (n=111)
Demographics 
Age (years ± sD) 78.4±9.2
Female (n) 41% (46)
Cardiac parameters (mean ± SD)
sBP (mmhg) 137±25
DBP (mmhg) 76±16
heart rate (bpm) 83±22
nYhA (latest known before hospitalization) 3.2±0.8




coronary heart disease 50% (56)
Atrial fibrillation 47% (52)
chronic kidney disease 36% (40)
Diabetes type ii 29% (32)
cOPD 10% (11)
number of daily medications (mean ± sD) 8±3
Education (n)
0–9 years 78% (86)
10 years 7% (8)
13 years 15% (17)
Occupation (n)
homemaker 16% (18)
Non-qualified manual labor 19% (21)
Qualified manual labor 56% (62)
University graduate 9% (10)
Relationship status (n)
living alone 44% (49)
in relationship 56% (62)
Abbreviations: BMi, body mass index; BnP, brain natriuretic peptide; cOPD, 
chronic obstructive pulmonary disease; DM ii, diabetes mellitus type 2; nYhA, 
new York heart Association; sD, standard deviation; sBP, systolic blood pressure; 
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Medication knowledge of heart failure patients
discharge (third interview). Knowledge at baseline and at 
the second interview refers to the medication taken before 
hospitalization. Knowledge at the third interview refers to 
medication taken according to the general practitioner’s 
record in the outpatient setting.
statistics
This evaluation is a descriptive, cross-sectional study. 
Data are presented as mean ± standard deviation (SD) of 
the mean and their distribution as percentages unless oth-
erwise specified. Baseline characteristics were presented 
using descriptive statistics with mean (SD) for quantitative 
variables, and numbers and percentages for categorical 
variables. Significance tests were repeated-measures analysis 
of variance using within-subjects factor group (hospital 
admission, hospital stay, and 3-month follow-up) including 
post hoc Bonferroni tests to assess individual differences 
with respect to medication knowledge. Values of P,0.05 
were considered significant. All statistical analyses were 
calculated using IBM SPSS statistics software (version 23.0; 
IBM Corporation, Armonk, NY, USA).
Results
Patients
The baseline characteristics of the 111 patients included 
in the study are summarized in Table 1. The mean age 
was 78.4±9.2 years, 59% were males, body mass index 
29.1±5.8 kg/m2, 56% were married/in relationship. On aver-
age, patients were categorized as New York Heart Association 
class III prior to hospitalization. Mean heart rate at hospital 
admission was 83±22 bpm. Mean systolic blood pressure 
was 137±25 mmHg. Median NT-proBNP plasma concentra-
tion in the overall population at baseline was 4,208 pg/mL 
(2,023–7,101 pg/mL [interquartile range]). The most common 
comorbidities were arterial hypertension (52%), coronary 
heart disease (50%), atrial fibrillation (47%), chronic kidney 
disease (36%), diabetes mellitus (29%), and chronic obstruc-
tive pulmonary disease (10%). Of the 111 patients included in 
the study, 20 died between the second and third interview.
number and types of prescribed drugs
At baseline, the patients took, on average, 4±2 prescribed 
drugs out of the 15 CV drug classes (Table 2). The average 
number of totally prescribed drugs was 8±3 per person. After 
3 months, each patient took 5±1 prescribed drugs out of the 
15 CV drug classes (totally number of daily medications 
was 9±3 per person). Hence, the number of drugs to be taken 
increased by an average of one per person due to additional 
prescription during hospitalization. Of the different drug 
classes, oral anticoagulation (OAC)/VKA (phenprocoumon) 
and aspirin were the best known (Table 2).
Knowledge of the number of daily 
medications
To assess the knowledge of the number of drugs taken, the 
number stated by the patient was compared to the prescribed 
number and calculated as percent deviation. Knowledge 
of the correct number of daily medications assessed at 
baseline and at home, 3 months after discharge is shown in 
Figure 1A and B.
In contrast to our expectation, medication knowledge 
decreased continuously from baseline to the third interview. 
At baseline, 41 patients (37%) stated the correct number 
of drugs taken, whereas only 16 patients (18%) knew the 
correct number after discharge (P=0.008). Figure 2 shows 
that the number of patients underestimating the number of 
drugs particularly increased after discharge. The number 
of patients exhibiting a deviation of 100% increased from 
six patients at baseline to 14 patients at the third interview. 
Figure 3 illustrates the amount of underestimation of the 
correct number of medications.
Knowledge of the number of daily 
medications based on nT-proBnP levels 
and age
To assess individual knowledge of heart-specific medication 
(correct number, name [generic or brand] out of the 15 CV 
drug classes, mode of action, dosage form, time-points of 
Table 2 Knowledge of prescribed hF-related drug classes 
(n: patient knew drug type)
Type of drug Knowledge (n/total pt with drug)
Baseline % Hospital % 3 months %
loop diuretics 38 (34/89) 38 (33/86) 49 (40/82)
β-Blockers 28 (24/87) 29 (24/83) 29 (22/75)
Ace inhibitors/AT1-receptor 
antagonists 
37 (31/84) 35 (28/80) 28 (21/76)
AsA 51 (24/47) 56 (25/45) 67 (22/33)
OAc (phenprocoumon) 83 (29/35) 91 (30/33) 70 (26/37)
Thiazides 42 (13/31) 46 (13/28) 29 (7/24)
calcium antagonists 23 (7/30) 24 (7/29) 32 (7/22)
Potassium-sparing diuretic 29 (6/21) 32 (6/19) 34 (12/35)
Antiplatelet drugs 8 (1/12) 8 (1/12) 20 (1/5)
Vasodilatators 17 (2/12) 17 (2/12) 21 (3/14)
Antiarrhythmics 45 (5/11) 50 (5/10) 45 (5/11)
Digitalis 13 (1/8) 13 (1/8) 0 (0/6)
nOAcs 38 (3/8) 50 (4/8) 67 (8/12)
Antihypertensive drugs 
(other)
67 (4/6) 50 (3/6) 33 (1/3)
Antianginal drugs 0 (0/3) 0  (0/3) 25 (1/4)
Abbreviations: Ace, angiotensin-converting enzyme; AsA, acetylsalicylic acid; 
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administration) in relation to the severity of heart failure and 
age, patients were stratified according to NT-proBNP and age 
tertiles. An inverse relation between medication knowledge 
and NT-proBNP levels was found at all three interviews (time-
points) as percent knowledge of the correct number of drugs 
decreased from tertile 1 to tertile 3 (Figure 4). Patients within 
the second age tertile (76–82 years) exhibited the best knowl-
edge compared to older or younger individuals (Figure 5).
Discussion
The main finding of this study was that the individual level 
of knowledge regarding heart failure-related medication was 
low in a cohort of CHF patients hospitalized for decompen-
sated heart failure and was inversely related to the severity 
of the disease but not with regard to age. In contrast to our 
expectations, the knowledge decreased even further from the 
time of hospital admission to the outpatient setting.
CHF is one of the most important causes of morbidity 
and mortality in Western countries, and symptoms related 
to CHF are the leading cause of hospitalization,11,12 contrib-
uting to 70% of the total treatment-related costs in patients 
aged .65 years, representing ~2% of the total health-care 
expenditure in industrialized countries.13 Patients with CHF 
require polypharmacy to control symptoms, slow disease pro-
gression, and decrease hospitalization and mortality.2 Health 
literacy, self-care skills, and, in particular, knowledge of 
one’s medication are a prerequisite for sustained medication 
adherence. Low literacy is associated with adverse outcomes 
in heart failure, including increased risk of hospitalization.4
Hospitalization for heart failure is closely and inversely 
linked to outcome in patients with chronic heart failure.14 
An important predictor of rehospitalization among other 
patient-related factors is medication non-adherence, which 







































Figure 1 (A) Patients’ knowledge of the number of drugs compared to approved number of prescribed drugs at home (baseline). each line indicates one patient 
(n=111). (B) Patients’ knowledge of the number of drugs compared to approved number of prescribed drugs at home (3 months). each line indicates one patient (n=91). 
0% deviation = correct number of drugs stated.





















Figure 2 Deviation of stated number of daily medications compared to prescribed 
number of daily medications.
Notes: Mean ± se. *P,0.05 knowledge at 3 months vs baseline (interview 1).















Figure 3 Patients’ knowledge of the number of drugs. Percent of patients stating the 
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Medication knowledge of heart failure patients
In our cohort, medication knowledge was lower than 
expected. Data from previous studies are heterogeneous and 
not easily comparable due to differences of the design and 
methodology. In a Swedish study population of elderly CHF 
patients, 55% could correctly name what medication had 
been prescribed 1 month after prescription.16 In a population 
of patients discharged from an internal medicine residency 
service at a community-based teaching hospital, 86% were 
aware that they had been prescribed new medicines, but fewer 
could correctly identify the name (64%) or number (74%) 
of new drugs in an interview between 4 and 18 days after 
discharge.17 Interestingly in our study, a lack of knowledge 
was not related to older age, a finding that is indirectly sup-
ported by a recent literature review, suggesting that older 
age alone is not related to poorer medication adherence in 
patients with CHF.18
Reasons for low health literacy and lack of knowledge 
are multifactorial and may even be a proxy for other deter-
minants such as cognitive impairment, severity of disease, 
socioeconomic characteristics, and other barriers to sufficient 
health care that are associated with poor outcomes.4 Apart 
from such patient-related factors, other factors related to 
health care providers (eg, communication strategies) are 
crucial and determine patients’ knowledge.
Patients in our study received standardized advice regard-
ing the type, dosage, and purpose of discharge medication 
by the attending physician at the time of discharge. During 
the outpatient course, follow-up visits were provided by 
office-based cardiologists and general practitioners pursu-
ing individual counseling strategies. Thus, the knowledge 
deficits observed may result from a lack of an educational 
strategy implemented in the clinical routine. Though the 
role for patient counseling and education seems obvious, 
health care providers tend to lose focus and – maybe even 
more important – are often unaware of literacy problems or 
overestimate patients’ understanding of health information 
and knowledge. Thus, appropriate strategies beyond standard 
instructions are not implemented.4
A variety of strategies and interventions focusing on edu-
cation to promote patients’ health literacy and knowledge can 
be found in the literature and are highlighted by the current 
heart failure guidelines and consensus documents.2,4 Educa-
tion was shown to improve knowledge, self-monitoring, 
medication adherence, time to hospitalization, and reduced 
days spent in the hospital.19 Patients who receive structured 
in-hospital education have higher knowledge scores at dis-
charge and 1 year later when compared with those who did 
not receive in-hospital education.20 Among the strategies to 
improve recall of medical advice, complementing verbal 
information with written instructions improved medication 
recall in a broad spectrum of patient populations.21–23 Imple-
mentation of an enhanced medication plan as an adjunct to 
the discharge conversation between physician and patient 
improved information transfer and patients’ knowledge 
of their drug treatment in a cohort of patients from several 
internal clinics in a university hospital. Interestingly, the 
intervention did not prolong the overall discharge process.21 
Although, to date, a clear survival benefit of in-hospital or 
discharge education could not be demonstrated, prior data 
















Figure 4 Medication knowledge depending on nT-proBnP level tertiles at the time 
of hospitalization (baseline). Percent of correct answers (correct number, name 
[generic or brand], mode of action, dosage form, time-points of administration) at 
baseline (n=111), at days 2–4 of hospital stay (n=106), and 3 months after discharge 
from the hospital (n=91) of surviving patients based on nTproBnP values at 
baseline. Median ± se.

















Figure 5 Medication knowledge depending on age tertiles. Percent of correct 
answers (correct number, name [generic or brand], mode of action, dosage form, 
time-points of administration) at baseline (n=111), at days 2–4 of hospital stay 
(n=106), and 3 months after discharge from the hospital (n=91) of surviving patients 
based on age tertiles. Median ± se.
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days of hospitalization, lower costs, and lower mortality rates 
within a 6-month follow-up.24
Previous studies in CHF patients like CogImpair-HF 
documented changes in cognitive function, which improved 
after recompensation.9 In contrast, in our study, individual 
medication knowledge decreased over time. This may be due 
to differences in the study design. In the CogImpair-HF study, 
patients where reevaluated after successful recompensation 
14±7 days after the index evaluation. In our study, patients 
were questioned on days 2–4 and after 3 months. At least, 
the time of the latter interview might have been postponed 
too far from the index event, leaving room for potential 
renewed decompensation and associated gaps of knowledge. 
On the other hand, the repeated interview itself may confer 
a training effect; however, this was clearly not sufficient to 
improve medication knowledge.
There are some limitations of this investigation. One is 
the relatively small sample size, which may not be regarded 
as representative of the overall heart failure population. 
Future studies with appropriate sample sizes are needed to 
confirm our study results. Another point is that we did not 
assess potential and clinically relevant cognitive disorders 
(eg, depression and dementia) before inclusion. Such disor-
ders are highly prevalent in heart failure and play a central 
role for patient-related adherence.25 Therefore, we cannot 
rule out completely that cognitive impairments associated 
with cardiac decompensation may have been confounded 
with symptoms of neurocognitive disorders. Due to structural 
limitations, it was not feasible to apply dedicated cognitive 
tests to measure the complete range of cognitive functions 
in our study. This point should be addressed by dedicated 
research protocols in future studies.
Conclusion and implications
In this observational study, we documented a low level of 
medication-associated knowledge in a contemporary cohort 
of CHF patients. In contrast to our hypothesis, knowledge 
decreased over time despite hospital care. The main reason 
for these findings may be found in the absence of structured 
counseling during hospitalization at discharge and during 
ambulatory care. Therefore, a central necessity is the recogni-
tion of the individual extent of patients’ health literacy and to 
identify patients at risk for low literacy, which may affect and 
compromise even basic skills. Moreover, this study underpins 
the need for focused patient counseling during hospitaliza-
tion, at discharge, and within the outpatient setting regard-
ing seamless pharmacotherapy in CHF patients. In order to 
reliably continue these therapies after discharge, continuous 
and structured communication between clinicians, primary 
care physicians, and patients is essential. Additional and 
innovative strategies addressing medicine management in 
this high-risk population are urgently needed.
Disclosure
The authors report no conflicts of interest in this work.
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